Very high power ablation trial for Atrial Fibrillation

This prospective, randomized, controlled, unblinded, multicenter study aims at comparing procedural time between conventional CLOSE-guided pulmonary vein isolation (PVI) (35W/50W) versus very high power radiofrequency delivery (90W) in atrial fibrillation patients scheduled for a first PVI.

It is planned to include 140 participants. Actual study start date is March 24, 2021. The researchers expect to complete the study by May 31, 2022.

One primary outcome measure is Procedural time, Comparison of the procedural time (in minutes) between groups.

The location of the study and inclusion/excluison criteria may be found here: https://ichgcp.net/clinical-trials-registry/NCT04784013

Clinical Research News

Upcoming Clinical Trials